- Home
- DRRX
DRRX
DURECT Corporation
as 07-26-2024 4:00pm EST
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | CUPERTINO |
| Market Cap: | 39.1M | IPO Year: | 2000 |
| Target Price: | $23.00 | AVG Volume (30 days): | 103.4K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.98 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.47 - $3.60 | Next Earning Date: | 08-07-2024 |
| Revenue: | $8,321,000 | Revenue Growth: | -57.16% |
| Revenue Growth (this year): | 20.68% | Revenue Growth (next year): | 78.35% |
Latest DURECT Corporation News
DRRX Breaking Stock News: Dive into DRRX Ticker-Specific Updates for Smart Investing
Zacks
a month ago
Are Medical Stocks Lagging DURECT (DRRX) This Year?
MT Newswires
2 months ago
Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment
PR Newswire
2 months ago
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
MT Newswires
2 months ago
Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says
Thomson Reuters StreetEvents
2 months ago
Q1 2024 DURECT Corp Earnings Call
GuruFocus.com
2 months ago
Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...
Zacks
2 months ago
Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
Associated Press Finance
2 months ago
Durect: Q1 Earnings Snapshot
Compare DRRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DRRX DURECT Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.